2022 - Research.com Immunology in Greece Leader Award
Member of the European Molecular Biology Organization (EMBO)
George Kollias mainly focuses on Immunology, Tumor necrosis factor alpha, Cytokine, Inflammation and Molecular biology. George Kollias regularly ties together related areas like Cancer research in his Immunology studies. His research in Tumor necrosis factor alpha intersects with topics in Stromal cell, Inflammatory bowel disease, Receptor, Cell biology and Multiple sclerosis.
His Cytokine study integrates concerns from other disciplines, such as Astrocyte and In vivo. The various areas that George Kollias examines in his Inflammation study include Delayed hypersensitivity, Interferon and Antibody. His studies in Molecular biology integrate themes in fields like Lipopolysaccharide, Transfection, Messenger RNA, Regulation of gene expression and p38 mitogen-activated protein kinases.
His scientific interests lie mostly in Tumor necrosis factor alpha, Immunology, Arthritis, Inflammation and Cancer research. His biological study deals with issues like Genetically modified mouse, which deal with fields such as Molecular biology and Gene expression. The concepts of his Immunology study are interwoven with issues in Transgene and Cell biology.
His biological study spans a wide range of topics, including Autoimmunity and Rheumatoid arthritis. His research investigates the link between Inflammation and topics such as Osteoclast that cross with problems in Bone resorption. His Cancer research study incorporates themes from Carcinogenesis, Fibroblast, Necrosis and RANKL.
Tumor necrosis factor alpha, Cancer research, Arthritis, Inflammation and Mesenchymal stem cell are his primary areas of study. Tumor necrosis factor alpha is a primary field of his research addressed under Internal medicine. His studies deal with areas such as Experimental autoimmune encephalomyelitis, Fibroblast, Pathogenesis and RANKL as well as Cancer research.
His Arthritis research includes elements of CXCL1, Autoimmunity, Rheumatoid arthritis and Programmed cell death. His Inflammation study is related to the wider topic of Immunology. His Immunology study combines topics from a wide range of disciplines, such as Disease, Genetic predisposition and Degranulation.
George Kollias mostly deals with Cancer research, Mesenchymal stem cell, Tumor necrosis factor alpha, Arthritis and Cell biology. George Kollias combines subjects such as Cancer cell, T cell, Adoptive cell transfer and Acquired immune system with his study of Cancer research. His Mesenchymal stem cell research is multidisciplinary, incorporating perspectives in Carcinogenesis, Stromal cell and Tumor microenvironment.
His Tumor necrosis factor alpha study necessitates a more in-depth grasp of Internal medicine. The study incorporates disciplines such as Inflammation and Programmed cell death, RIPK1, Necroptosis in addition to Arthritis. His studies in Cell biology integrate themes in fields like Deubiquitinating enzyme, Ubiquitin binding and Inflammatory arthritis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Transcriptional Landscape of the Mammalian Genome
P. Carninci;T. Kasukawa;S. Katayama;J. Gough.
Position-independent, high-level expression of the human β-globin gene in transgenic mice
Frank Grosveld;Greet Blom van Assendelft;David R. Greaves;George Kollias.
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
J. Keffer;L. Probert;H. Cazlaris;S. Georgopoulos.
The EMBO Journal (1991)
THE TRANSMEMBRANE FORM OF TUMOR NECROSIS FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR NECROSIS FACTOR RECEPTOR
Matthias Grell;Eleni Douni;Harald Wajant;Matthias Löhden.
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Séverine Boillée;Koji Yamanaka;Christian S. Lobsiger;Neal G. Copeland.
Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.
Dimitris Kontoyiannis;Manolis Pasparakis;Theresa Torres Pizarro;Fabio Cominelli.
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity.
Paola Bezzi;Maria Domercq;Liliana Brambilla;Rossella Galli.
Nature Neuroscience (2001)
Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.
M Pasparakis;L Alexopoulou;V Episkopou;G Kollias.
Journal of Experimental Medicine (1996)
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.
Robert J. Moore;David M. Owens;Gordon Stamp;Caroline Arnott.
Nature Medicine (1999)
TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway
Calin D. Dumitru;Jeffrey D. Ceci;Christos Tsatsanis;Dimitris Kontoyiannis.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: